CTOs on the Move

Beam Therapeutics

www.beamtx.com

 
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam Team Is: • A community of fearless innovators • Rigorous and honest in our research • Listening ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.beamtx.com
  • 26 Landsdowne Street 2nd Floor
    Cambridge, MA USA 02139
  • Phone: 857.327.8775

Executives

Name Title Contact Details
Nicholas Meghri
 Associate Director, IT Business Partnership Profile
Brian Riley
 Senior Vice President of Technical Operations Profile
Brad Dutot
 Vice President, Information Technology Profile

Funding

Beam Therapeutics raised $13M on 04/27/2018
Beam Therapeutics raised $74M on 05/14/2018
Beam Therapeutics raised $11M on 03/06/2019
Beam Therapeutics raised $260M on 01/19/2021

Similar Companies

DUSA Pharmaceuticals

DUSA Pharmaceuticals is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medsite

Medsite is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CoreRx Pharma

CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. From its state-of-the-art, multi-site campus in Clearwater, Florida and its early product development center of excellence in San Rafael, California, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale and across a range of dosage forms.

AlliancePharma

The vision of AlliancePharma Inc. is to offer a service that is human, professional and personalized, and fosters the development of the skills of the replacement pharmacists and pharmacy technicians. In the long term, AlliancePharma Inc. strives to increase and improve the value of its privileged position in the area of pharmacy replacement services, as well as diversifying its activities in high value added sectors linked to health.

Nidek

NIDEK offers a wide array of equipment designed for the diagnosis and treatment of retinal diseases, glaucoma, and other vision-impairing afflictions.